Immunopathology of rejection: Do the rules of solid organ apply to vascularized composite allotransplantation?

Current Opinion in Organ Transplantation

Volumn 20, Issue 6, 2015, Pages 596-601

  Thaunat, Olivier ^a,b,c   Badet, Lionel ^a   Dubois, Valérie ^d   Kanitakis, Jean ^a   Petruzzo, Palmina ^a   Morelon, Emmanuel ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Antibody mediated rejection; Rejection; T cell mediated rejection; Vascularized composite allotransplantation

Indexed keywords

ANTIBODY MEDIATED REJECTION; BONE MARROW TRANSPLANTATION; CHRONIC GRAFT REJECTION; DISEASE PREDISPOSITION; GRAFT REJECTION; HUMAN; IMMUNOPATHOLOGY; NONHUMAN; ORGAN; REVIEW; SKIN; T LYMPHOCYTE; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; ANIMAL; BONE MARROW; IMMUNOLOGY; ORGAN TRANSPLANTATION; PATHOLOGY;

ANTIBODY;

ANIMALS; ANTIBODIES; BONE MARROW; GRAFT REJECTION; HUMANS; ORGAN TRANSPLANTATION; T-LYMPHOCYTES; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;

EID: 84947128427     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000242     Document Type: Review

References (46)

1. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6:686-688.
2. Benichou G. Direct and indirect antigen recognition: the pathways to allograft immune rejection. Front Biosci 1999; 4:D476-D480.
3. Celli S, Albert ML, Bousso P. Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy. Nat Med 2011; 17:744-749.
4. Wood KJ, Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012; 93:1-10.
5. Thaunat O. Humoral immunity in chronic allograft rejection: puzzle pieces come together. Transplant Immunol 2012; 26:101-106.
6. Zarkhin V, Kambham N, Li L, et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008; 74:664-673.
7. Halloran PF. T-cell-mediated rejection of kidney transplants: a personal viewpoint. Am J Transplant 2010; 10:1126-1134.
8. Batista FD, Harwood NE. The who, how and where of antigen presentation to B cells. Nat Rev Immunol 2009; 9:15-27.
9. Thaunat O, Field AC, Dai J, et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci USA 2005; 102:14723-14728.
10. Thaunat O, Graff-Dubois S, Fabien N, et al. A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection. Kidney Int 2012; 81:207-219.
11. Thaunat O, Graff-Dubois S, Brouard S, et al. Immune responses elicited in tertiary lymphoid tissues display distinctive features. PLoS ONE 2010; 5:e11398.
12. Thaunat O, Patey N, Caligiuri G, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol 2010; 185:717-728.
13. Pouliquen E, Koenig A, Chen CC, et al. Recent advances in renal transplantation: antibody-mediated rejection takes center stage. F1000 Prime Reports 2015; 7:51.
14. Smith RN, Colvin RB. Chronic alloantibody mediated rejection. Semin Immunol 2012; 24:115-121.
15. Mildner A, Jung S. Development and function of dendritic cell subsets. Immunity 2014; 40:642-656.
16. Lau AH, de Creus A, Lu L, Thomson AW. Liver tolerance mediated by antigen presenting cells: fact or fiction? Gut 2003; 52:1075-1078.
17. Little MH. Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 2006; 17:2390-2401.
18. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276:60-66.
19. Thaunat O, Badet L, El-Jaafari A, et al. Composite tissue allograft extends a helping hand to transplant immunologists. Am J Transplant 2006; 6:2238-2242.
20. Li Z, Benghiat FS, Charbonnier LM, et al. CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice. Am J Transplant 2008; 8:2527-2536.
21. Siemionow M, Izycki D, Ozer K, et al. Role of thymus in operational tolerance induction in limb allograft transplant model. Transplantation 2006; 81:1568-1576.
22. Schneeberger S, Gorantla VS, Brandacher G, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surgery 2013; 257:345-351.
23. Kanitakis J, Jullien D, Petruzzo P, et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 2003; 76:688-693.
24. Halloran PF, Chang J, Famulski K, et al. Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients. J Am Soc Nephrol 2015; 26:1711-1720.
25. Petruzzo P, Gazarian A, Kanitakis J, et al. Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. Ann Surg 2015; 261:213-220.
26. Schneeberger S, Landin L, Jableki J, et al. Achievements and challenges in composite tissue allotransplantation. Transplant Int 2011; 24:760-769.
27. Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plastic Reconstr Surg 1971; 47:425-431.
28. Kanitakis J, Morelon E, Petruzzo P, et al. Self-renewal capacity of human epidermal Langerhans cells: observations made on a composite tissue allograft. Exp Dermatol 2011; 20:145-146.
29. Kanitakis J, Petruzzo P, Dubernard JM. Turnover of epidermal Langerhans' cells. New Engl J Med 2004; 351:2661-2662.
30. Hoeffel G, Wang Y, Greter M, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med 2012; 209:1167-1181.
31. Conrad A, Brunet AS, Hervieu V, et al. Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient. Transplant Infect Dis 2013; 15:E182-E186.
32. Petruzzo P, Kanitakis J, Testelin S, et al. Clinicopathological findings of chronic rejection in a face grafted patient. Transplantation 2015. [Epub ahead of print]
33. Petruzzo P, Kanitakis J, Badet L, et al. Long-term follow-up in composite tissue allotransplantation: in-depth study of five (hand and face) recipients. Am J Transplant 2011; 11:808-816.
34. Serre JE, Michonneau D, Bachy E, et al. Maintaining calcineurin inhibition after the diagnosis of posttransplant lymphoproliferative disorder improves renal graft survival. Kidney Int 2014; 85:182-190.
35. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12:388-399.
36. Sicard A, Ducreux S, Rabeyrin M, et al. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. J Am Soc Nephrol 2015; 26:457-467.
37. Thaunat O, Louedec L, Dai J, et al. Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis. Arterioscler Thromb Vasc Biol 2006; 26:2359-2365.
38. Chandraker A, Arscott R, Murphy GF, et al. The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotrans-plant. Am Transplant 2014; 14:1446-1452.
39. Landin L, Cavadas PC, Ibanez J, et al. CD3+-mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 2009; 87:776-781.
40. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14:272-283.
41. Kaufman CL, Ouseph R, Blair B, et al. Graft vasculopathy in clinical hand transplantation. Am J Transplant 2012; 12:1004-1016.
42. Bachelet T, Couzi L, Lepreux S, et al. Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome. Am J Transplant 2013; 13:2855-2864.
43. Martin L, Guignier F, Bocrie O, et al. Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy. Transplantation 2005; 79:1459-1461.
44. Jackson AM, Sigdel TK, Delville M, et al. Endothelial cell antibodies associated with novel targets and increased rejection. J Am Soc Nephrol 2015; 26:1161-1171.
45. Pober JS, Jane-wit D, Qin L, Tellides G. Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy. Arterioscler Thromb Vasc Biol 2014; 34:1609-1614.
46. Uehara S, Chase CM, Kitchens WH, et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005; 175:3424-3430.